Biotech

Medtronic PLC (NYSE: MDT)’s announcement that it is commencing an offer for more than $4 billion in debt securities should help the company manage its tax headwind, according to Morgan Stanley.  The Analyst David Lewis maintained an Equal-weight rating on Medtronic with a $100 price...

Krystal Biotech Inc (NASDAQ: KRYS) announced positive Phase 2 data for KB103 Monday and said the gene therapy received the Regenerative Medicine Advanced Therapy designation from the FDA. The Phase 2 results are close to a “best-case scenario”, according to Guggenheim Securities....

A life sciences company whose business combines drug research with modern technologies is part of the IPO slate of this week. The IPO Terms Adaptive Biotechnologies is planning to offer 12.5 million shares in an IPO to be priced between $15 and $17, according an amended filing dated June 19. At the...

Shares of micro-cap biotech Conatus Pharmaceuticals Inc (NASDAQ: CNAT) were sinking further into penny stock territory Tuesday after two announcements made Monday after the market close. Conatus said it has engaged Oppenheimer to explore strategic alternatives in a bid to enhance...

Acer Therapeutics Inc (NASDAQ: ACER) shares were trading down more than 75% Tuesday after it received a letter from the Food and Drug Administration regarding its drug application for Edsivo in the treatment of vascular Ehlers-Danlos syndrome. The FDA said it is necessary to conduct an...

Shares of Aldeyra Therapeutics Inc (NASDAQ: ALDX), a thinly traded micro-cap biotech, plummeted Tuesday morning. What Happened Aldeyra, which focuses on therapies for immune-mediated diseases, reported its Phase 3 trial dubbed SOLACE that evaluated its reproxalap, code-named ADX-102 (a topical...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 24) Global Blood Therapeutics Inc (NASDAQ: GBT) Krystal Biotech Inc (NASDAQ: KRYS)(reported positive Phase 2 results for its lead gene therapy...

The dermatology-focused biotech BIOFRONTERA AG/ADR (NASDAQ: BFRA) has made some major steps toward growing its operations in the U.S. and Europe, and Benzinga interviewed CFO Thomas Schaffer about them. The interview has been edited for length and clarity. Benzinga: I noticed that Biofrontera...

Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV) shares traded higher last week after the micro-cap biotech said it requested a Type A meeting with the FDA regarding the complete response letter for the new drug application for its investigational compound Contepo to treat complicated urinary...

Krystal Biotech Inc (NASDAQ: KRYS) shares spiked after the gene therapy company announcing positive results from its KB103 clinical trial on Monday.  The stock was higher by 46.11% at $42.59 at the time of publication Monday.  KB103 is Krystal’s main product that aims to treat...

Shares of thinly traded micro-cap biotech Minerva Neurosciences Inc (NASDAQ: NERV) spiked higher on Monday. What Happened Minerva announced results of a Phase 2b study that evaluated its seltorexant, codenamed MIN-202, in patients with insomnia disorder that met the primary endpoint of...

Uncertainty over Bristol-Myers Squibb Co (NYSE: BMY)'s impending deal to acquire Celgene Corporation (NASDAQ: CELG) and an adverse clinical trial readout were dragging the shares of the large-cap pharma company lower Monday. FTC Concerns Over Celgene Deal  Bristol-Myers said in a...

The upward trajectory of prescription drug prices in the U.S. has drawn the ire of lawmakers. Prices of drugs are staggeringly high in the U.S. when compared to other developed countries such as Japan and in Europe. House lawmakers are discussing a plan that could work to curb high...